PRTA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 113818 min ago

@ $27.01

Wydano: 14 vas. 2024 @ 22:42

Zwrot: -15.11%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: -1.57 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States...

Stats
Dzisiejszy wolumen	544 246
Średni wolumen	626 303
Kapitalizacja rynkowa	1.23B
EPS	$0 ( 2024-05-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.31
ATR14	$0.0300 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Ford David A	Buy	85 000	Stock Option (Right to Buy)
2024-03-01	Ford David A	Buy	0
2024-02-27	Zago Wagner M.	Buy	85 000	Stock Option (Right to Buy)
2024-02-27	Walker Karin L	Buy	54 000	Stock Option (Right to Buy)
2024-02-27	Smith Brandon S.	Buy	85 000	Stock Option (Right to Buy)

INSIDER POWER
77.74
Last 98 transactions
Buy: 1 184 000 \| Sell: 192 000

Wolumen Korelacja

Długi: -0.03 (neutral)

Krótki: -0.56 (weak negative)

Signal:(58.969) Neutral

Prothena Corporation PLC Korelacja

10 Najbardziej pozytywne korelacje
TSLA	0.958
ASTS	0.942
AEHR	0.941
OM	0.939
WW	0.937
ZLAB	0.937
MSEX	0.936
ASLE	0.936
FWRD	0.935
IDBA	0.934

10 Najbardziej negatywne korelacje
KVSC	-0.96
BCOR	-0.952
MCAA	-0.94
HCNE	-0.939
BHAC	-0.938
APXI	-0.937
FTIV	-0.936
VMGA	-0.935
RNLC	-0.935
GEEX	-0.934

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Prothena Corporation PLC Korelacja - Waluta/Towar

0.33
( neutral )

0.53
( weak )

0.00
( neutral )

0.17
( neutral )

-0.46
( neutral )

0.67
( moderate )

Prothena Corporation PLC Finanse

Annual	2023
Przychody:	$91.37M
Zysk brutto:	$82.96M (90.79 %)
EPS:	$-2.76

FY	2023
Przychody:	$91.37M
Zysk brutto:	$82.96M (90.79 %)
EPS:	$-2.76

FY	2022
Przychody:	$53.91M
Zysk brutto:	$47.16M (87.49 %)
EPS:	$-2.47

FY	2021
Przychody:	$200.58M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$1.510

Financial Reports:

No articles found.

Prothena Corporation PLC

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.